Ditte Drejer1,2, Sami Béji3, Anna Munk Nielsen1, Søren Høyer4, Gitte Wrist Lam3, Jørgen B Jensen1,2. 1. a Department of Urology , Aarhus University Hospital , Aarhus , Denmark. 2. b Department of Urology , Hospital of West Jutland , Holstebro , Denmark. 3. c Department of Urology , Herlev Hospital , Herlev , Denmark. 4. d Institute of Pathology , Aarhus University Hospital , Aarhus , Denmark.
Abstract
OBJECTIVE: This multicenter study investigated whether the use of narrow-band imaging (NBI) in flexible cystoscopy could improve diagnostics to a degree where clinical management was relevantly changed. MATERIALS AND METHODS: From May 2014 to June 2015, 955 patients were enrolled at three Danish urological departments. Patients had either hematuria (n = 483) or known recurrent non-muscle-invasive bladder cancer (NMIBC) (n = 472). High-definition (HD) cystoscopy was performed in white light (WL) and a preliminary clinical decision was made. Then, a second cystoscopy was performed in NBI and a conclusive clinical decision was made. A difference between the two decisions that had a clinical impact on the patient was considered clinically relevant. RESULTS: Pathology was found in 216 WL cystoscopies, and additional pathology in 15 NBI cystoscopies (6.9%). Based on NBI, pathology was suspected in 23 patients (3.1%) in whom a WL cystoscopy revealed no tumor. In total, NBI changed the clinical decision relevantly in 1.9% of the patients. In hematuria patients, the calculated sensitivities of both NBI and WL were identically high, whereas sensitivity in patients with known NMIBC was significantly higher in NBI compared to WL (NBI: 100.0% vs WL: 83.2%, p < .05). NBI had a lower specificity compared to WL, especially in follow-up cystoscopies (NBI: 86.5% vs WL: 92.1, p < .05). CONCLUSION: NBI can be a useful tool in clinical decision making as a supplement to WL because it yields a significantly higher detection rate than WL cystoscopy alone. This is particularly relevant in patients with known recurrent NMIBC.
OBJECTIVE: This multicenter study investigated whether the use of narrow-band imaging (NBI) in flexible cystoscopy could improve diagnostics to a degree where clinical management was relevantly changed. MATERIALS AND METHODS: From May 2014 to June 2015, 955 patients were enrolled at three Danish urological departments. Patients had either hematuria (n = 483) or known recurrent non-muscle-invasive bladder cancer (NMIBC) (n = 472). High-definition (HD) cystoscopy was performed in white light (WL) and a preliminary clinical decision was made. Then, a second cystoscopy was performed in NBI and a conclusive clinical decision was made. A difference between the two decisions that had a clinical impact on the patient was considered clinically relevant. RESULTS: Pathology was found in 216 WL cystoscopies, and additional pathology in 15 NBI cystoscopies (6.9%). Based on NBI, pathology was suspected in 23 patients (3.1%) in whom a WL cystoscopy revealed no tumor. In total, NBI changed the clinical decision relevantly in 1.9% of the patients. In hematuriapatients, the calculated sensitivities of both NBI and WL were identically high, whereas sensitivity in patients with known NMIBC was significantly higher in NBI compared to WL (NBI: 100.0% vs WL: 83.2%, p < .05). NBI had a lower specificity compared to WL, especially in follow-up cystoscopies (NBI: 86.5% vs WL: 92.1, p < .05). CONCLUSION: NBI can be a useful tool in clinical decision making as a supplement to WL because it yields a significantly higher detection rate than WL cystoscopy alone. This is particularly relevant in patients with known recurrent NMIBC.
Entities:
Keywords:
Flexible cystoscopy; narrow-band imaging; non-muscle-invasive bladder cancer
Authors: Francesco Soria; M Pilar Laguna; Morgan Roupret; Patricio Garcia-Marchinena; Mariano Sebastián Gonzalez; Tomonori Habuchi; Erkan Erkan; Anthony Ng; Paolo Gontero; Jean de la Rosette Journal: BJU Int Date: 2021-06-13 Impact factor: 5.969
Authors: Seung Bin Kim; Sung Goo Yoon; Jonghyun Tae; Jae Yoon Kim; Ji Sung Shim; Sung Gu Kang; Jun Cheon; Jeong Gu Lee; Je Jong Kim; Seok Ho Kang Journal: Investig Clin Urol Date: 2018-02-08
Authors: D Oswald; M Pallauf; T R W Herrmann; C Netsch; B Becker; K Lehrich; A Miernik; D S Schöb; K D Sievert; A J Gross; J Westphal; L Lusuardi; S Deininger Journal: Urologe A Date: 2022-01-04 Impact factor: 0.639